Fulltext

228. Secukinumab, A Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis and Inhibits Radiographic Progression: Efficacy and Safety Data from a Phase 3 Randomized, Multicentre, Double-Blind, Placebo-Controlled Study

Tahir, Hasan ; Mease, Philip ; McInnes, Iain B. ; Kirkham, Bruce ; Kavanaugh, Arthur ; Rahman, Proton ; van der Heijde, Désirée ; Landewé, Robert ; Nash, Peter ; Pricop, Luminita ; Yuan, Jiacheng ; Richards, Hanno ; Mpofu, Shephard

In: Rheumatology, 2015, vol. 54, p. i137-i138

Ajouter à la liste personnelle
    Titre
    • 228. Secukinumab, A Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis and Inhibits Radiographic Progression: Efficacy and Safety Data from a Phase 3 Randomized, Multicentre, Double-Blind, Placebo-Controlled Study
    Auteur
    • Tahir, Hasan. Rheumatology, Whipps Cross University Hospital, London, UK, Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, USA, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Rheumatology, UC San Diego School of Medicine, San Diego, CA, USA, Rheumatology, Memorial University, St John's, NL, Canada, Rheumatology, Leiden University Medical Centre, Leiden, Rheumatology, University of Amsterdam and Atrium Medical Centre, Amsterdam, The Netherlands, Rheumatology, University of Queensland, Brisbane, Australia, Integrated Hospital Care, Rheumatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA and Integrated Hospital Care, Rheumatology, Novartis Pharma AG, Basel, Switzerland
    • Mease, Philip. Rheumatology, Whipps Cross University Hospital, London, UK, Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, USA, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Rheumatology, UC San Diego School of Medicine, San Diego, CA, USA, Rheumatology, Memorial University, St John's, NL, Canada, Rheumatology, Leiden University Medical Centre, Leiden, Rheumatology, University of Amsterdam and Atrium Medical Centre, Amsterdam, The Netherlands, Rheumatology, University of Queensland, Brisbane, Australia, Integrated Hospital Care, Rheumatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA and Integrated Hospital Care, Rheumatology, Novartis Pharma AG, Basel, Switzerland
    • McInnes, Iain B.. Rheumatology, Whipps Cross University Hospital, London, UK, Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, USA, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Rheumatology, UC San Diego School of Medicine, San Diego, CA, USA, Rheumatology, Memorial University, St John's, NL, Canada, Rheumatology, Leiden University Medical Centre, Leiden, Rheumatology, University of Amsterdam and Atrium Medical Centre, Amsterdam, The Netherlands, Rheumatology, University of Queensland, Brisbane, Australia, Integrated Hospital Care, Rheumatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA and Integrated Hospital Care, Rheumatology, Novartis Pharma AG, Basel, Switzerland
    • Kirkham, Bruce. Rheumatology, Whipps Cross University Hospital, London, UK, Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, USA, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Rheumatology, UC San Diego School of Medicine, San Diego, CA, USA, Rheumatology, Memorial University, St John's, NL, Canada, Rheumatology, Leiden University Medical Centre, Leiden, Rheumatology, University of Amsterdam and Atrium Medical Centre, Amsterdam, The Netherlands, Rheumatology, University of Queensland, Brisbane, Australia, Integrated Hospital Care, Rheumatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA and Integrated Hospital Care, Rheumatology, Novartis Pharma AG, Basel, Switzerland
    • Kavanaugh, Arthur. Rheumatology, Whipps Cross University Hospital, London, UK, Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, USA, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Rheumatology, UC San Diego School of Medicine, San Diego, CA, USA, Rheumatology, Memorial University, St John's, NL, Canada, Rheumatology, Leiden University Medical Centre, Leiden, Rheumatology, University of Amsterdam and Atrium Medical Centre, Amsterdam, The Netherlands, Rheumatology, University of Queensland, Brisbane, Australia, Integrated Hospital Care, Rheumatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA and Integrated Hospital Care, Rheumatology, Novartis Pharma AG, Basel, Switzerland
    • Rahman, Proton. Rheumatology, Whipps Cross University Hospital, London, UK, Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, USA, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Rheumatology, UC San Diego School of Medicine, San Diego, CA, USA, Rheumatology, Memorial University, St John's, NL, Canada, Rheumatology, Leiden University Medical Centre, Leiden, Rheumatology, University of Amsterdam and Atrium Medical Centre, Amsterdam, The Netherlands, Rheumatology, University of Queensland, Brisbane, Australia, Integrated Hospital Care, Rheumatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA and Integrated Hospital Care, Rheumatology, Novartis Pharma AG, Basel, Switzerland
    • van der Heijde, Désirée. Rheumatology, Whipps Cross University Hospital, London, UK, Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, USA, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Rheumatology, UC San Diego School of Medicine, San Diego, CA, USA, Rheumatology, Memorial University, St John's, NL, Canada, Rheumatology, Leiden University Medical Centre, Leiden, Rheumatology, University of Amsterdam and Atrium Medical Centre, Amsterdam, The Netherlands, Rheumatology, University of Queensland, Brisbane, Australia, Integrated Hospital Care, Rheumatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA and Integrated Hospital Care, Rheumatology, Novartis Pharma AG, Basel, Switzerland
    • Landewé, Robert. Rheumatology, Whipps Cross University Hospital, London, UK, Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, USA, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Rheumatology, UC San Diego School of Medicine, San Diego, CA, USA, Rheumatology, Memorial University, St John's, NL, Canada, Rheumatology, Leiden University Medical Centre, Leiden, Rheumatology, University of Amsterdam and Atrium Medical Centre, Amsterdam, The Netherlands, Rheumatology, University of Queensland, Brisbane, Australia, Integrated Hospital Care, Rheumatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA and Integrated Hospital Care, Rheumatology, Novartis Pharma AG, Basel, Switzerland
    • Nash, Peter. Rheumatology, Whipps Cross University Hospital, London, UK, Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, USA, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Rheumatology, UC San Diego School of Medicine, San Diego, CA, USA, Rheumatology, Memorial University, St John's, NL, Canada, Rheumatology, Leiden University Medical Centre, Leiden, Rheumatology, University of Amsterdam and Atrium Medical Centre, Amsterdam, The Netherlands, Rheumatology, University of Queensland, Brisbane, Australia, Integrated Hospital Care, Rheumatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA and Integrated Hospital Care, Rheumatology, Novartis Pharma AG, Basel, Switzerland
    • Pricop, Luminita. Rheumatology, Whipps Cross University Hospital, London, UK, Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, USA, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Rheumatology, UC San Diego School of Medicine, San Diego, CA, USA, Rheumatology, Memorial University, St John's, NL, Canada, Rheumatology, Leiden University Medical Centre, Leiden, Rheumatology, University of Amsterdam and Atrium Medical Centre, Amsterdam, The Netherlands, Rheumatology, University of Queensland, Brisbane, Australia, Integrated Hospital Care, Rheumatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA and Integrated Hospital Care, Rheumatology, Novartis Pharma AG, Basel, Switzerland
    • Yuan, Jiacheng. Rheumatology, Whipps Cross University Hospital, London, UK, Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, USA, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Rheumatology, UC San Diego School of Medicine, San Diego, CA, USA, Rheumatology, Memorial University, St John's, NL, Canada, Rheumatology, Leiden University Medical Centre, Leiden, Rheumatology, University of Amsterdam and Atrium Medical Centre, Amsterdam, The Netherlands, Rheumatology, University of Queensland, Brisbane, Australia, Integrated Hospital Care, Rheumatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA and Integrated Hospital Care, Rheumatology, Novartis Pharma AG, Basel, Switzerland
    • Richards, Hanno. Rheumatology, Whipps Cross University Hospital, London, UK, Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, USA, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Rheumatology, UC San Diego School of Medicine, San Diego, CA, USA, Rheumatology, Memorial University, St John's, NL, Canada, Rheumatology, Leiden University Medical Centre, Leiden, Rheumatology, University of Amsterdam and Atrium Medical Centre, Amsterdam, The Netherlands, Rheumatology, University of Queensland, Brisbane, Australia, Integrated Hospital Care, Rheumatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA and Integrated Hospital Care, Rheumatology, Novartis Pharma AG, Basel, Switzerland
    • Mpofu, Shephard. Rheumatology, Whipps Cross University Hospital, London, UK, Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, USA, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK, Rheumatology, UC San Diego School of Medicine, San Diego, CA, USA, Rheumatology, Memorial University, St John's, NL, Canada, Rheumatology, Leiden University Medical Centre, Leiden, Rheumatology, University of Amsterdam and Atrium Medical Centre, Amsterdam, The Netherlands, Rheumatology, University of Queensland, Brisbane, Australia, Integrated Hospital Care, Rheumatology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA and Integrated Hospital Care, Rheumatology, Novartis Pharma AG, Basel, Switzerland
    Type de document
    • Postprint
    Identifiant OAI-PMH
    • oai:doc.rero.ch:304748